Login Register Cart 0
Generic placeholder image

Recent Patents on Biotechnology

Editor-in-Chief

ISSN (Print): 1872-2083
ISSN (Online): 2212-4012

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Levothyroxine Sodium - Thyroid Hormone Replacement Therapy for Hypothyroidism: A Review of Patent Literature

Author(s): Uddeshya Upadhyay*, Pratik Ashwinbhai Vora, Rakesh Patel and Bijal Prajapati

Volume 17, Issue 3, 2023

Published on: 11 January, 2023

Page: [245 - 256] Pages: 12

DOI: 10.2174/1872208317666221212124113

Price: $65

Abstract

Background: Levothyroxine Sodium is a thyroid hormone replacement therapy for Hypothyroidism. Levothyroxine Sodium is approved to treat Hypothyroidisim, to suppress thyroid hormone release from cancerous thyroid nodules, and to prevent the growth of goiters. In addition, it is also used to treat conditions such as myxedema, cretinism, and obesity.

Objective: This assessment highlights the overview of the recent patents of Levothyroxine Sodium. This review includes patents grouped in sections like product patents, process patents, and composition-related patents, along with the treatment methodology. The objective of this article is to impel pseudoscientists to all existing patents in a solitary place.

Methods: Data were gathered from various internet-based resources, including Patentscope ® (WIPO), Worldwide Espacenet® (EPO), Google Patents, and InPASS (Indian patent database).

Results: Several new processes and composition-related patents of Levothyroxine Sodium have been reported. Further, due to the problem of photosensitivity, oxidation during development, and stability of Levothyroxine Sodium formulation, several excipients are tried in these patents to stabilize the same. However, the formulation of Levothyroxine Sodium with better characteristics needs to be developed.

Conclusion: Extensive exposure has been carried out towards various processes for the preparation of Levothyroxine Sodium and the composition of the same. This sort of dynamic exploration will clear the path for many generic players, which will lead to the reduction of the expense of the composition and accordingly enhance global health care at a less expensive cost.

« Previous Next »
Graphical Abstract

[1]
Intosh JMc.. What is hypothyroidism? 2018. Available from: https://www.medicalnewstoday.com/articles/ 163729
[2]
Department of health and human services. Medical News Today. Available from: https://www.govinfo. gov/content/pkg/FR-1997-08-14/pdf/97-21575.pdf
[3]
Yannis P, Lioumis K. Method for the preparation of a Levothyroxine solution. Patent WO2012120338, 2012.
[4]
Orange book: Approved drug products with therapeutic equivalence evaluations. Available from: https:// www.accessdata.fda.gov/scripts/cder/ob/search_produ ct.cfm
[5]
Ginger LG, Anthony PZ. Process for producing thyroxine. Patent US2889363, 1959.
[6]
Frederick CP, Timothy TA. Process for producing Sodium 1-thyroxine comprising the oxidative coupling of a diido-1-tyrosine catalyzed by a manganese salt in the presence of an amine. Patent WO1996011904, 1996.
[7]
Mafatlal KB, Renugadevi G, Naik RM, et al. An improved process for the preparation of Levothyroxine Sodium with reduced levels of impurities. Patent W02009136249, 2009.
[8]
Swapnil SD, Adinath MJ, Himanshu MG, et al. A process for the preparation of Levothyroxine and salts thereof. Patent CA2944116, 2015.
[9]
Rao ChAP. Novel process for the preparation of Levothyroxine Sodium. Patent WO2015011573, 2015.
[10]
You J, Yu Q. Preparation method of Levothyroxine Sodium. Patent CN109761830, 2019.
[11]
Mousa SA, Davis FB, Davis PJ. Thyroid hormone analogs and methods of use. Patent WO2006031922, 2006.
[12]
Konieczna M, Krohn H, Wanda R, Schlehahn H, Strozyk MA, Papadimitriou DC. Pharmaceutical formulation comprising Levothyroxine Sodium. Patent US20070110803, 2007.
[13]
Scott Iii Linzy O. Methods and compositions for treating thyroid-related medical conditions with reduced folates. Patent EP3053583, 2016.
[14]
Zhu D, Min Z, Chen Z, Bei W, Wu Z. Drug for treating Hypothyroidism. Patent CN106074550, 2016.
[15]
Mun YS. Use of thyroid hormone for treatment of choroidal disease. Patent WO2018030881, 2018.
[16]
Alejandro MMS, Raymond GB, Livia LN, Nadia CV. Use of Levothyroxine for the treatment of diabetes mellitus. Patent WO2019030422, 2019.
[17]
Jivn-Ren Chen. Stable dosage of Levothyroxine Sodium and process of production. Patent US5225204, 1993.
[18]
Groenewoud PJ, Hai W. Stabilized composition of Levothyroxine Sodium medication and method for its production. Patent US5635209, 1997.
[19]
Alexander SS, Marion N. Pharmaceutical preparation containing Sodium Levothyroxine and the process of its preparation. Patent CZ200174, 2001.
[20]
Ritter SC, Springer WSE, Robert G. Liothyronine Sodium and Levothyroxine Sodium combination. Patent US20020193440, 2002.
[21]
Franz G, Strauss EA, Dimmenna PA, et al. Stabilized pharmaceutical and thyroid hormone compositions and method of preparation. Patent US7067148, 2006.
[22]
Franz G. Methods of administering Levothyroxine pharmaceutical compositions. Patent US7101569, 2006.
[23]
Ioulia Tseti. Dry powder comprising LevothyroxineSodium is administrated via inhalator. Patent EP1811987, 2007.
[24]
Ioulia Tseti. Pharmaceutical Levothyroxine Sodium formulas. Patent GR1007213, 2011.
[25]
Georgios L, Angelos K, Ilias K. Drinkable pharmaceutical solutions for the treatment of Hypothyroidism. Patent GR20100100508, 2012.
[26]
Jiang Z. Levothyroxine formulations. Patent EP2750664, 2014.
[27]
Ioulia T. Stable pharmaceutical dosage forms comprising Levothyroxine Sodium. Patent EP2932963, 2015.
[28]
Ping H, Fen R, Biao Z, et al. Pharmaceutical composition containing Levothyroxine Sodium. Patent CN110075305, 2019.
[29]
Li P, Zhang Y, Wu L. Orally disintegrating tablet containing Levothyroxine Sodium. Patent CN110420191, 2019.
[30]
Shen H. Composition with Levothyroxine Sodium and application of composition. Patent CN110507623, 2020.
[31]
Parikh K, Patel M, Mandal JK. Liquid parenteral compositions of Levothyroxine. Patent US20210059967, 2021.
[32]
Jack A, Rashid SM, Rajendra G. Oral film composition comprising Levothyroxine. Patent WO2021100063, 2021.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy